Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF.

Psychiatry Res. 2009 Nov 30;174(2):152-7. doi: 10.1016/j.pscychresns.2009.04.011. Epub 2009 Oct 22.

PMID:
19853417
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling.

Muthén B, Brown HC.

Stat Med. 2009 Nov 30;28(27):3363-85. doi: 10.1002/sim.3721.

PMID:
19731223
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Changes in brain function during administration of venlafaxine or placebo to normal subjects.

Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B.

Clin EEG Neurosci. 2008 Oct;39(4):175-81.

PMID:
19044214
[PubMed - indexed for MEDLINE]
4.

Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.

Bares M, Brunovsky M, Kopecek M, Novak T, Stopkova P, Kozeny J, Sos P, Krajca V, Höschl C.

Eur Psychiatry. 2008 Aug;23(5):350-5. doi: 10.1016/j.eurpsy.2008.03.001. Epub 2008 May 2.

PMID:
18450430
[PubMed - indexed for MEDLINE]
5.

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH.

Am J Psychiatry. 2008 Mar;165(3):342-51. doi: 10.1176/appi.ajp.2007.06111868. Epub 2008 Jan 2.

PMID:
18172020
[PubMed - indexed for MEDLINE]
6.

Shapes of early change in psychotherapy under routine outpatient conditions.

Stulz N, Lutz W, Leach C, Lucock M, Barkham M.

J Consult Clin Psychol. 2007 Dec;75(6):864-74.

PMID:
18085904
[PubMed - indexed for MEDLINE]
7.

Is there a common resilience mechanism underlying antidepressant drug response? Evidence from 2848 patients.

Stassen HH, Angst J, Hell D, Scharfetter C, Szegedi A.

J Clin Psychiatry. 2007 Aug;68(8):1195-205.

PMID:
17854243
[PubMed - indexed for MEDLINE]
8.

Multidimensional patterns of change in outpatient psychotherapy: the phase model revisited.

Stulz N, Lutz W.

J Clin Psychol. 2007 Sep;63(9):817-33.

PMID:
17674397
[PubMed - indexed for MEDLINE]
9.

A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.

Perahia DG, Pritchett YL, Kajdasz DK, Bauer M, Jain R, Russell JM, Walker DJ, Spencer KA, Froud DM, Raskin J, Thase ME.

J Psychiatr Res. 2008 Jan;42(1):22-34. Epub 2007 Apr 18.

PMID:
17445831
[PubMed - indexed for MEDLINE]
10.

The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder.

Hunter AM, Cook IA, Leuchter AF.

Psychiatr Clin North Am. 2007 Mar;30(1):105-24. Review.

PMID:
17362807
[PubMed - indexed for MEDLINE]
11.

Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implications.

Cusin C, Fava M, Amsterdam JD, Quitkin FM, Reimherr FW, Beasley CM Jr, Rosenbaum JF, Perlis RH.

J Clin Psychiatry. 2007 Jan;68(1):52-7.

PMID:
17284130
[PubMed - indexed for MEDLINE]
12.

Timing of clinical improvement and symptom resolution in the treatment of major depressive disorder.

Papakostas GI, Petersen T, Sklarsky KG, Nierenberg AA, Alpert JE, Fava M.

Psychiatry Res. 2007 Jan 15;149(1-3):195-200. Epub 2006 Dec 8.

PMID:
17157390
[PubMed - indexed for MEDLINE]
13.

Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.

Bares M, Brunovsky M, Kopecek M, Stopkova P, Novak T, Kozeny J, Höschl C.

J Psychiatr Res. 2007 Apr-Jun;41(3-4):319-25. Epub 2006 Aug 4.

PMID:
16889798
[PubMed - indexed for MEDLINE]
14.

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M; STAR*D Study Team.

Am J Psychiatry. 2006 Jan;163(1):28-40.

PMID:
16390886
[PubMed - indexed for MEDLINE]
15.

Examining differential effects of psychological treatment of depressive disorder: an application of trajectory analyses.

Cuijpers P, van Lier PA, van Straten A, Donker M.

J Affect Disord. 2005 Dec;89(1-3):137-46. Epub 2005 Nov 7.

PMID:
16274750
[PubMed - indexed for MEDLINE]
16.

Is there a delay in the antidepressant effect? A meta-analysis.

Posternak MA, Zimmerman M.

J Clin Psychiatry. 2005 Feb;66(2):148-58.

PMID:
15704999
[PubMed - indexed for MEDLINE]
17.

A rating scale for depression.

HAMILTON M.

J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62. No abstract available.

PMID:
14399272
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

General growth mixture modeling for randomized preventive interventions.

Muthén B, Brown CH, Masyn K, Jo B, Khoo ST, Yang CC, Wang CP, Kellam SG, Carlin JB, Liao J.

Biostatistics. 2002 Dec;3(4):459-75.

PMID:
12933592
[PubMed]
Free Article
19.

Validating 'hard' and 'soft' phenotypes within the bipolar spectrum: continuity or discontinuity?

Akiskal HS.

J Affect Disord. 2003 Jan;73(1-2):1-5.

PMID:
12507732
[PubMed - indexed for MEDLINE]
20.

Early changes in prefrontal activity characterize clinical responders to antidepressants.

Cook IA, Leuchter AF, Morgan M, Witte E, Stubbeman WF, Abrams M, Rosenberg S, Uijtdehaage SH.

Neuropsychopharmacology. 2002 Jul;27(1):120-31.

PMID:
12062912
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk